Bank of New York Mellon’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Bank of New York Mellon's BMY Position: Q2 2026 in Review
Bank of New York Mellon reduced its Bristol-Myers Squibb (BMY) stake by 6.4% in Q2 2026, selling an estimated $85M and leaving 21,821,384 shares worth $1.26B. The position accounts for 0.21% of the portfolio, ranked #86.
Bank of New York Mellon first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.68B in Q3 2020. 1,988 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Bank of New York Mellon held 21,821,384 shares of Bristol-Myers Squibb worth $1.26B as of Q2 2026.
- Bank of New York Mellon sold 1,479,953 Bristol-Myers Squibb shares in Q2 2026, an estimated $85M.
- Bristol-Myers Squibb made up 0.21% of Bank of New York Mellon's portfolio in Q2 2026, its #86 holding.
- Bank of New York Mellon first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's Bristol-Myers Squibb position peaked at $1.68B in Q3 2020.
- 1,988 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.